Clark Eliana sold NTLA
January 3, 2024 · Form 4 insider transaction
Clark Eliana sold 307 shares of Intellia Therapeutics, Inc. at $30.12 per share, a transaction worth $9.2K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
307
Price
$30.12
Total value
$9.2K
InsiderClark Eliana
RoleOfficer
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateJanuary 3, 2024
Filing dateJanuary 5, 2024
Shares owned after45,146
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Sale of 307 shares that were acquired under the Intellia Therapeutics, Inc. 2016 Employee Stock Purchase Plan on December 31, 2023.